Takeda selected for the sixth consecutive year for Dow Jones Sustainability Asia Pacific Index
Takeda Pharmaceutical Company Ltd. (“Takeda”, TSE: 4502) has been selected for the Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific) for the sixth...
For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
For the seventh consecutive year, Roche (SIX: RO, ROG; OTCQX: RHHBY) has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology...
Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts
Today announced plans to establish a new drug delivery and device innovation center in Cambridge, Massachusetts – a strategic location that will help attract...
U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Patients with Previously Untreated Advanced Melanoma
Application includes CheckMate -066, a clinical trial of Opdivo vs. dacarbazine chemotherapy in patients who had not received prior therapy CheckMate -066 marked the...
Particulate Systems Acquires Subsieve Autosizer (SAS) from HEL
Particulate Systems, a brand of Micromeritics, has completed the full acquisition of Subsieve Autosizer from HEL. The agreement was finalised on March 18, 2015....
G-CON Manufacturing Selected to Build Aseptic Formulation and Filling PODs for UTHSC
G-CON Manufacturing has been selected to build a multi-POD ISO Class 7 Formulation and Filling Suite for the University of Tennessee Health Science Center...
Novartis data at ERS 2014 show once-daily Ultibro® Breezhaler® is superior in reducing COPD flare ups compared to Seretide®
Novartis presented new data that demonstrated once-daily Ultibro® Breezhaler® (indacaterol/glycopyrronium bromide) was superior in reducing exacerbations (flare ups) and improving lung function compared to...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...